MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Neuraxis (NRXS) Ownership - Who owns Neuraxis?

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults... Show more

Profile

Industry
N/A
Address
11611 North Meridian Street
Phone
+1 812 689-0791
Employees
24
Web
https://www.neuraxis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
88.67M
P/E Ratio
N/A
Total Cash
7.08M
Projected Growth
N/A
Total Debt
353.52K
Revenue
4.28M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
0.43 USD as % of share price
View a ticker or compare two or three
NRXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
11611 North Meridian Street
Phone
+1 812 689-0791
Employees
24
Web
https://www.neuraxis.com